Aptiv Solutions, a biopharmaceutical and medical device development services company and pioneer in adaptive clinical trial design, simulation and execution, announces publication of a Tufts Center ...
Inconsistencies in the way adverse event reports are filled out and sent to the US Food and Drug Administration (FDA) could mislead drug safety professionals and cause the wrong conclusions to be ...
The Tufts Center for the Study of Drug Development (Tufts CSDD) is a non-profit, multi-disciplinary academic research group located on the campus of Tufts University. Tufts CSDD provides strategic ...
New research by Tufts Center for the Study of Drug Development (CSDD) documents the growing importance of real-world data ...
Drug developers plan to improve R&D management and operations in 2015 in order to cut development costs and avoid the glare of payers increasingly intent on containing drug prices, the Tufts Center ...
NOTTINGHAM, England--(BUSINESS WIRE)--Tufts Center for the Study of Drug Development (CSDD) today published a white paper sharing study results that indicate Quotient Sciences’ Translational ...
A vigorous development pipeline predicts that the recent increased pace of biotech approvals will continue for the following decade, showing that biopharmaceuticals accounted for 35% of all new drug ...
Testing CSDD ... bnody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results